Next Article in Journal
The Role of Continuous Glucose Monitoring, Diabetes Smartphone Applications, and Self-Care Behavior in Glycemic Control: Results of a Multi-National Online Survey
Next Article in Special Issue
Artificial Intelligence vs. Natural Stupidity: Evaluating AI Readiness for the Vietnamese Medical Information System
Previous Article in Journal
Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification
Previous Article in Special Issue
Methods Used to Assess the 3D Accuracy of Dental Implant Positions in Computer-Guided Implant Placement: A Review
Open AccessArticle

Driving Type 2 Diabetes Risk Scores into Clinical Practice: Performance Analysis in Hospital Settings

ITACA, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
Endocrinology and Nutrition Department, University Hospital La Fe, Avinguda de Fernando Abril Martorell, 106, 46026 València, Spain
Mixed Research Unit of Endocrinology, Nutrition and Dietetics, La Fe Health Research Institute, Avenida Fernando Abril Martorell, Torre 106 A 7planta, 46026 València, Spain
Unidad Mixta de Reingeniería de Procesos Sociosanitarios, Instituto de Investigación Sanitaria del Hospital Universitario y Politecnico La Fe Bulevar Sur S/N, 46026 Valencia, Spain
Home Care and Telemedicine Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(1), 107;
Received: 22 December 2018 / Revised: 9 January 2019 / Accepted: 15 January 2019 / Published: 17 January 2019
(This article belongs to the Special Issue The Future of Artificial Intelligence in Clinical Medicine)
Electronic health records and computational modelling have paved the way for the development of Type 2 Diabetes risk scores to identify subjects at high risk. Unfortunately, few risk scores have been externally validated, and their performance can be compromised when routine clinical data is used. The aim of this study was to assess the performance of well-established risk scores for Type 2 Diabetes using routinely collected clinical data and to quantify their impact on the decision making process of endocrinologists. We tested six risk models that have been validated in external cohorts, as opposed to model development, on electronic health records collected from 2008-2015 from a population of 10,730 subjects. Unavailable or missing data in electronic health records was imputed using an existing validated Bayesian Network. Risk scores were assessed on the basis of statistical performance to differentiate between subjects who developed diabetes and those who did not. Eight endocrinologists provided clinical recommendations based on the risk score output. Due to inaccuracies and discrepancies regarding the exact date of Type 2 Diabetes onset, 76 subjects from the initial population were eligible for the study. Risk scores were useful for identifying subjects who developed diabetes (Framingham risk score yielded a c-statistic of 85%), however, our findings suggest that electronic health records are not prepared to massively use this type of risk scores. Use of a Bayesian Network was key for completion of the risk estimation and did not affect the risk score calculation (p > 0.05). Risk score estimation did not have a significant effect on the clinical recommendation except for starting pharmacological treatment (p = 0.004) and dietary counselling (p = 0.039). Despite their potential use, electronic health records should be carefully analyzed before the massive use of Type 2 Diabetes risk scores for the identification of high-risk subjects, and subsequent targeting of preventive actions. View Full-Text
Keywords: Risk scores; prediction; T2DM; clinical data; screening Risk scores; prediction; T2DM; clinical data; screening
Show Figures

Figure 1

MDPI and ACS Style

Martinez-Millana, A.; Argente-Pla, M.; Valdivieso Martinez, B.; Traver Salcedo, V.; Merino-Torres, J.F. Driving Type 2 Diabetes Risk Scores into Clinical Practice: Performance Analysis in Hospital Settings. J. Clin. Med. 2019, 8, 107.

AMA Style

Martinez-Millana A, Argente-Pla M, Valdivieso Martinez B, Traver Salcedo V, Merino-Torres JF. Driving Type 2 Diabetes Risk Scores into Clinical Practice: Performance Analysis in Hospital Settings. Journal of Clinical Medicine. 2019; 8(1):107.

Chicago/Turabian Style

Martinez-Millana, Antonio; Argente-Pla, María; Valdivieso Martinez, Bernardo; Traver Salcedo, Vicente; Merino-Torres, Juan F. 2019. "Driving Type 2 Diabetes Risk Scores into Clinical Practice: Performance Analysis in Hospital Settings" J. Clin. Med. 8, no. 1: 107.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop